Ceri Oldreive

2.8k citations

26 papers · 1.8k indexed · 1 hit paper · h-index 15

Molecular Biology top 10%
Oncology top 5%
Immunology top 10%
Genetics top 5%
Physiology top 10%

Co-authors: Tatjana Stanković A. Malcolm R. Taylor Gayle Doherty Catherine Rice‐Evans Grant S. Stewart Paul Moss Guy Pratt Jarkko Ylanko
Topics: Chronic Lymphocytic Leukemia Research (11 papers)Lymphoma Diagnosis and Treatment (6 papers)Nitric Oxide and Endothelin Effects (4 papers)
Cited by: Oncology Genetics Molecular Biology
Journals: Cell Journal of Clinical Oncology The Journal of Cell Biology
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Ceri Oldreive

26 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damage

2009 599 citations Grant S. Stewart, Stephanie Panier et al. Cell profile →

Peers

Countries citing papers authored by Ceri Oldreive

Since Specialization

Citations

This map shows the geographic impact of Ceri Oldreive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ceri Oldreive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ceri Oldreive more than expected).

Fields of papers citing papers by Ceri Oldreive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ceri Oldreive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ceri Oldreive. The network helps show where Ceri Oldreive may publish in the future.

Co-authorship network of co-authors of Ceri Oldreive

This figure shows the co-authorship network connecting the top 25 collaborators of Ceri Oldreive. A scholar is included among the top collaborators of Ceri Oldreive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ceri Oldreive. Ceri Oldreive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts 2017 ·Oncotarget ·Nicholas Davies,Marwan Kwok,(unknown),Ceri Oldreive,(unknown),Helen Parry,Edward Smith,Angelo Agathanggelou,Guy Pratt,A. Malcolm R. Taylor,Paul Moss,Mike Griffiths,Tatjana Stanković	10
2	NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma 2016 ·Oncotarget ·Helen Parry,Tom H. Stevens,Ceri Oldreive,(unknown),Tina McSkeane,Zbigniew Rudzki,Shankara Paneesha,Caroline Chadwick,Tatjana Stanković,Guy Pratt,Jianmin Zuo,Paul Moss	48
3	ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells 2015 ·Blood ·Marwan Kwok,Nicholas Davies,Angelo Agathanggelou,Edward Smith,Ceri Oldreive,Eva Petermann,Grant S. Stewart,(unknown),Alan Lau,Guy Pratt,Helen Parry,A. Malcolm R. Taylor,Paul Moss,Peter Hillmen,Tatjana Stanković	211
4	T-cell number and subtype influence the disease course of primary chronic lymphocytic leukaemia xenografts in alymphoid mice 2015 ·Disease Models & Mechanisms ·Ceri Oldreive,Anna Skowrońska,Nicholas Davies,Helen Parry,Angelo Agathanggelou,Sergey Krysov,Graham Packham,Zbigniew Rudzki,(unknown),Katerina Vrzalikova,Paul G. Murray,Elena Odintsova,Guy Pratt,A. Malcolm R. Taylor,Paul Moss,Tatjana Stanković	6
5	The impact of SF3B1 mutations in CLL on the DNA-damage response 2014 ·Leukemia ·G. Doreen te Raa,(unknown),Veronika Navrkalová,Anna Skowrońska,Perry D. Moerland,(unknown),Ceri Oldreive,Hanneke N. Monsuur,Martin Trbušek,Jitka Malčíková,Martin Lodén,Carsten Geisler,Jennifer Hüllein,Alexander Jethwa,Thorsten Zenz,Šárka Pospı́šilová,Tatjana Stanković,Marinus H. J. van Oers,Arnon P. Kater,Eric Eldering	61
6	The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53 2014 ·Oncogene ·(unknown),Tracey Perry,Sarah Berhane,Ceri Oldreive,Anastasia Zlatanou,Luke Williams,Victoria Weston,Tatjana Stanković,Pamela Kearns,Klaus Pors,Roger J.A. Grand,Grant S. Stewart	6
7	BET inhibition as a single or combined therapeutic approach in primary paediatric B-precursor acute lymphoblastic leukaemia 2013 ·Blood Cancer Journal ·David Da Costa,Angelo Agathanggelou,Tracey Perry,Victoria Weston,Eva Petermann,Anastasia Zlatanou,Ceri Oldreive,Wenbin Wei,Grant S. Stewart,(unknown),Emily Smith,Pamela Kearns,Stefan Knapp,Tatjana Stanković	63
8	Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial 2012 ·Journal of Clinical Oncology ·Anna Skowrońska,Anton Parker,(unknown),Ceri Oldreive,Zadie Davis,Sue Richards,Martin J.S. Dyer,Estella Matutes,David González,A. Malcolm R. Taylor,Paul Moss,Peter Thomas,David Oscier,Tatjana Stanković	77
9	SF3B1 Mutations in CLL Are Equivalent to p53/ATM Dysfunction and Cause Defective Puma Upregulation in Response to Chemotherapy 2012 ·Blood ·Doreen te Raa,Ingrid A. M. Derks,Dieuwertje M. Luijks,(unknown),Hanneke N. Monsuur,Ceri Oldreive,Alexander Jethwa,Jennifer Hüllein,Tatjana Stanković,Thorsten Zenz,Marinus H. J. van Oers,Arnon P. Kater,Eric Eldering	7
10	Effects of Nitric Oxide on the Survival and Neuritogenesis of Cerebellar Purkinje Neurons 2011 ·Journal of Molecular Neuroscience ·Ceri Oldreive,(unknown),Gayle Doherty	7
11	Effects of Tumour Necrosis Factor-alpha on Developing Cerebellar Granule and Purkinje Neurons In Vitro 2010 ·Journal of Molecular Neuroscience ·Ceri Oldreive,Gayle Doherty	13
12	The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damagebreakdown → 2009 ·Cell ·Grant S. Stewart,Stephanie Panier,Kelly Townsend,Abdallah Al-Hakim,Nadine K. Kolas,Edward S. Miller,Shinichiro Nakada,Jarkko Ylanko,(unknown),Megan Mendez,Ceri Oldreive,Jan Wildenhain,Andrea Tagliaferro,Laurence Pelletier,Nadine Taubenheim,Anne Durandy,Philip J. Byrd,Tatjana Stanković,A. Malcolm R. Taylor,Daniel Durocher	599
13	Neurotrophic effects of leptin on cerebellar Purkinje but not granule neurons in vitro 2008 ·Neuroscience Letters ·Ceri Oldreive,Jenni Harvey,Gayle Doherty	28
14	Developmental changes in the response of murine cerebellar granule cells to nitric oxide 2008 ·Neurochemistry International ·Ceri Oldreive,(unknown),Gayle Doherty	7
15	Neuroprotective actions of leptin on central and peripheral neurons in vitro 2008 ·Neuroscience ·Gayle Doherty,Ceri Oldreive,Jenni Harvey	47
16	Neurotoxic effects of homocysteine on cerebellar Purkinje neurons in vitro 2006 ·Neuroscience Letters ·Ceri Oldreive,Gayle Doherty	37
17	Embryonic cerebellar granule cells are resistant to necrosis induced by homocysteine 2005 ·Developmental Brain Research ·(unknown),Ceri Oldreive,John B. Mackie,Gayle Doherty	14
18	CD14-dependent clearance of apoptotic cells by human macrophages: the role of phosphatidylserine 2003 ·Cell Death and Differentiation ·Andrew Devitt,Sarah Pierce,Ceri Oldreive,William Shingler,Christopher D. Gregory	74
19	The mechanisms for nitration and nitrotyrosine formationin vitroandin vivo: Impact of diet 2001 ·Free Radical Research ·Ceri Oldreive,Catherine Rice‐Evans	60
20	Lack of influence of dietary nitrate/nitrite on plasma nitrotyrosine levels measured using a competitive inhibition of binding ELISA assay 2001 ·Free Radical Research ·Ceri Oldreive,Nicholas J. Bradley,Richard Bruckdorfer,Catherine Rice‐Evans	19

About Ceri Oldreive

Ceri Oldreive is a scholar working on Genetics, Endocrine and Autonomic Systems and Biophysics, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Oncology (626 citations), Genetics (234 citations) and Molecular Biology (1.2k citations). Ceri Oldreive has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Tatjana Stanković, A. Malcolm R. Taylor, Gayle Doherty, Catherine Rice‐Evans, Grant S. Stewart, Paul Moss, Guy Pratt, Jarkko Ylanko, Megan Mendez and Nadine Taubenheim. Their work appears in journals such as Cell, Journal of Clinical Oncology and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact